Jazz Pharmaceuticals
JAZZ
#2012
Rank
S$10.84 B
Marketcap
$179.36
Share price
-2.09%
Change (1 day)
5.11%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$1.91

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.89. In 2022 the company made an earnings per share (EPS) of -$4.74 an increase over its 2021 EPS that were of -$7.20.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.91-59.77%
2022-$4.74-34.2%
2021-$7.20-224.83%
2020$5.77-53.25%
2019$12.3423.59%
2018$9.99-8.24%
2017$10.8923.74%
2016$8.8022.12%
2015$7.20478.49%
2014$1.25-74.93%
2013$4.97-27.11%
2012$6.8269.1%
2011$4.03245.98%
2010$1.16-462.5%
2009-$0.32-96.7%
2008-$9.75-27.04%
2007-$13.3665.47%
2006-$8.07-4.59%
2005-$8.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.38 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$11.10-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.01-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.68 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel